Inhibitors of human immunodeficiency virus replication
The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
Bristol-Myers Squibb Company
C A A C A
C07D A61K A61K C07D A61P
inventional inventional inventional inventional inventional
Annapurna George L. Guo Nicholas A. Samuel David R.
Pendri Trainor Li Meanwell Gerritz Langley